These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9987703)

  • 21. A review of the cardiac systemic side-effects of antihistamines: ebastine.
    Moss AJ; Chaikin P; Garcia JD; Gillen M; Roberts DJ; Morganroth J
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():200-5. PubMed ID: 10444238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of reboxetine on cardiac repolarization.
    Fleishaker JC; Francom SF; Herman BD; Knuth DW; Azie NE
    Clin Pharmacol Ther; 2001 Sep; 70(3):261-9. PubMed ID: 11557914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.
    Boinpally R; Gad N; Gupta S; Periclou A
    Clin Ther; 2014 Nov; 36(11):1638-49. PubMed ID: 25236915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.
    Honig PK; Woosley RL; Zamani K; Conner DP; Cantilena LR
    Clin Pharmacol Ther; 1992 Sep; 52(3):231-8. PubMed ID: 1526078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
    Muirhead GJ; Faulkner S; Harness JA; Taubel J
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):37S-43S. PubMed ID: 11879258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.
    Abbas R; Leister C; El Gaaloul M; Chalon S; Sonnichsen D
    Clin Ther; 2012 Sep; 34(9):2011-9.e1. PubMed ID: 22884766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of pharmacokinetic interaction between tiagabine and erythromycin.
    Thomsen MS; Groes L; Agersø H; Kruse T
    J Clin Pharmacol; 1998 Nov; 38(11):1051-6. PubMed ID: 9824787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emedastine-ketoconazole: pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
    Herranz U; Rusca A; Assandri A
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):102-9. PubMed ID: 11396749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.
    Martin DE; Zussman BD; Everitt DE; Benincosa LJ; Etheredge RC; Jorkasky DK
    J Clin Psychopharmacol; 1997 Dec; 17(6):451-9. PubMed ID: 9408807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.
    Miceli JJ; Smith M; Robarge L; Morse T; Laurent A
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):71S-76S. PubMed ID: 10771458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac effects of ebastine and other antihistamines in humans.
    Moss AJ; Morganroth J
    Drug Saf; 1999; 21 Suppl 1():69-80; discussion 81-7. PubMed ID: 10597870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions.
    Boetsch C; Parrott N; Fowler S; Poirier A; Hainzl D; Banken L; Martin-Facklam M; Hofmann C
    Clin Pharmacokinet; 2016 Feb; 55(2):237-47. PubMed ID: 26341813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
    Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
    Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C; Wagenmann M; Vossen-Holzenkamp S
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study.
    Venkatakrishnan K; Rader M; Ramanathan RK; Ramalingam S; Chen E; Riordan W; Trepicchio W; Cooper M; Karol M; von Moltke L; Neuwirth R; Egorin M; Chatta G
    Clin Ther; 2009; 31 Pt 2():2444-58. PubMed ID: 20110052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
    Hatorp V; Hansen KT; Thomsen MS
    J Clin Pharmacol; 2003 Jun; 43(6):649-60. PubMed ID: 12817528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ; Preston RA; Swan SK
    Clin Pharmacokinet; 2007; 46(6):525-34. PubMed ID: 17518511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.